TrialHuman vaccines & immunotherapeutics2019

Pre-marketing immunogenicity and safety of a lyophilized purified human diploid cell rabies vaccine produced from microcarrier cultures: a randomized clinical trial.

Xingyu Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.